HJ Science Co., Ltd. will convene its Board of Directors on 28 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026, according to an announcement released on 18 August 2026.
The meeting agenda includes consideration of the consolidated interim statements and subsequent public disclosure of the results. The Board currently comprises four executive directors (including Chairman and CEO Dr. Ji Jianxin), four non-executive directors, and four independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments